Abstract

BackgroundPatient research partners (PRPs) are people with a disease who collaborate in a research team as partners. The aim of this systematic literature review (SLR) was to assess barriers and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Involving patients as research partners in research in rheumatology: a literature review in 2023
Codruta Zabalan ... Jette Primdahl
RMD Open | VOL. 9
Codruta Zabalan, et. al.Codruta Zabalan ... Jette Primdahl
01 Nov 2023
Designing a Web-Based Psychological Intervention for Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: User-Centered Design Approach.
Erik M G Olsson ... Sophia Monica Humphries
Journal of medical Internet research | VOL. 22
Erik M G Olsson, et. al.Erik M G Olsson ... Sophia Monica Humphries
17 Sep 2020
SAT0642-HPR Collaboration of Patients and Health Professionals in Development and Research of Care-Intervention: Case Example Presented by A Patient Research Partner
B Maat ... J.W Ammerlaan
Annals of the Rheumatic Diseases | VOL. 75
B Maat, et. al.B Maat ... J.W Ammerlaan
01 Jun 2016
Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP.
Maarten De Wit ... Clifton O Bingham
The Journal of rheumatology | VOL. 43
Maarten De Wit, et. al.Maarten De Wit ... Clifton O Bingham
15 Apr 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers